Radiation and nitroimidazoles in supratentorial high grade gliomas: a second clinical trial.

As a continuation of a previous controlled trial using "high-dose" metronidazole as a specific sensitizer of hypoxic cells, we used a more efficient nitroimidazole derivative (misonidazole, MISO) in combination with higher doses of radiation in patients with supratentorial high-grade astro...

Descripción completa

Detalles Bibliográficos
Autores principales: Urtasun, R., Feldstein, M. L., Partington, J., Tanasichuk, H., Miller, J. D., Russell, D. B., Agboola, O., Mielke, B.
Formato: Texto
Lenguaje:English
Publicado: Nature Publishing Group 1982
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2011055/
https://www.ncbi.nlm.nih.gov/pubmed/6285947

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2011055/
https://www.ncbi.nlm.nih.gov/pubmed/6285947

Ejemplares similares